
New Survey Reveals Pediatricians Overwhelmingly Prefer Genexa's Ingredients Over Children's Tylenol
The results of this study—drawn from a double-blind national survey of U.S. pediatricians (FRC 2025) — found that an overwhelming majority of respondents prefer Genexa's oral suspension ingredient profiles for treating their own patient's pain and fever over the ingredient profiles in Tylenol ® 's top-selling comparable products 1.
'This should be a wake-up call for the industry,' said David Johnson, CEO and Co-Founder of Genexa. 'Pediatricians are sending a clear message: it's time to change our medicines. We are so proud to be the first company to make clean medicine because we believe that no parent should have to choose between clean ingredients and effective relief.'
A Moment of Trust in Pediatric Care
The survey results arrive as transparency and ingredient awareness take center stage for parents and healthcare providers. With 88% of parents identifying pediatricians as their most trusted source for children's health advice 2, these pediatrician preference results signal a strong alignment between medical guidance and parental values.
'Fewer artificial additives isn't a trend, it's a clinical and parental priority,' said Dr. Shayna Smith, board-certified pediatrician and Genexa partner. 'Genexa reflects what we as doctors want to see more of: clean, simple, and effective formulas for acute symptom relief.'
The Brand at the Center of a Clean Medicine Movement
These findings reinforce broader market trends: clean label products, those made with familiar, simple ingredients and without artificial additives, are growing faster than their conventional counterparts 3. Genexa is leading that shift in the medicine aisle, offering children's medicine from pain relievers to cold and flu treatments that are made with the same effective ingredients as traditional brands, but without additives such as artificial preservatives, artificial sweeteners, dyes, or common allergens. With high standards for safety and efficacy, Genexa gives families a new choice that aligns with their health priorities without compromise.
'Knowing that the medical professionals who have made a commitment to children's health prefer our ingredients is incredibly validating,' added Johnson. 'We hope this empowers even more parents to make the switch to clean medicine.'
Genexa's full line of products are available at retailers nationwide including Target, Walmart, Whole Foods, Walgreens, CVS, and more as well as Amazon. For more information on the survey results and to learn more about Genexa's commitment to clean medicine, please visit genexa.com.
About Genexa:
Founded with the goal of revolutionizing the medicine aisle, Genexa makes medicines with the same effective active ingredients as leading brands, but without artificial additives including artificial preservatives, sweeteners, and dyes. Made in the USA with globally sourced non-GMO ingredients, Genexa medicines are certified gluten-free and free of the top 9 common allergens. As a Certified B Corp, Genexa is leading the clean medicine movement and setting a new standard for what goes into children's and family health products.
1 The ingredient lists that the pediatricians reviewed in the children's pain and fever category were from the following products: Children's Tylenol Pain + Fever Suspension (Dye Free Cherry); Children's Tylenol Pain + Fever Suspension (Dye Free Natural Apple); Children's Tylenol Pain + Fever Suspension (Grape); Genexa Kids' Pain & Fever (Blueberry and Cherry). The ingredient lists that the pediatricians reviewed in the infants' pain and fever category were from the following products: Infants' Tylenol Pain + Fever Suspension (Dye Free Cherry); Infants' Tylenol Pain + Fever Suspension (Grape); Genexa Infants' Pain & Fever (Blueberry and Cherry).
2 2023 RAPID National Survey, Stanford University,
3 2024 Clean Label Products Driving Retail Sales as They Gain Preference Among Consumers, Acosta Group,

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
3 hours ago
- Business Wire
Wellness Innercell Expands into Indonesian Home Shopping Market with Joint Care
CHANGWON, South Korea--(BUSINESS WIRE)-- Wellness Innercell, a cosmetics manufacturer and distributor of health functional food, announced that it will launch its flagship health supplement product, 'Joint Care,' on Indonesian home shopping channels starting this October. 'In addition to our ongoing exports to the U.S., we will focus on pioneering new markets in Southeast Asia, starting with Indonesia in the second half of this year.' Share According to the company, Joint Care addresses the side effects and cost burden often associated with conventional joint supplements. It helps relieve joint pain while supporting cartilage protection, nerve and muscle health, dental care, bone density improvement, enhanced physical performance, immune system function, and energy production. Certified by the Korean Ministry of Food and Drug Safety as a health functional food, it contains key active ingredients at the maximum daily allowable dosage and includes probiotics to promote digestive health. Leveraging a multi-formula technology, Joint Care combines a variety of functional ingredients into a single all-in-one tablet, offered in convenient PTP (Press-Through Package) form for easy carrying and consumption. 'In addition to our ongoing exports to the U.S., we will focus on pioneering new markets in Southeast Asia, starting with Indonesia in the second half of this year,' said Kang Ik-geun, CEO of Wellness Innercell. About Wellness Innercell Wellness Innercell is a Korea-based manufacturer and distributor specializing in cosmetics and health functional foods, dedicated to delivering innovative, science-backed solutions for better living. Leveraging advanced formulation technology and strict quality standards, Wellness Innercell aims to expand its global presence and provide trusted health products to consumers worldwide.


Business Wire
7 hours ago
- Business Wire
Amber Specialty Pharmacy Begins Dispensing Newly Approved BRINSUPRI™ (brensocatib) for Non-Cystic Fibrosisbronchiectasis (NCFB)
OMAHA, Neb.--(BUSINESS WIRE)--Amber Specialty Pharmacy, a pioneer in specialty pharmacy for more than 25 years, today announced it is now dispensing BRINSUPRI™ (brensocatib) following the medication's U.S. Food and Drug Administration (FDA) approval as the first treatment specifically indicated to reduce pulmonary exacerbations in adults and adolescents with non-cystic fibrosis bronchiectasis, a chronic neutrophil-mediated airway disease. 'Our nationally recognized clinical program is ready to ensure rapid access, personalized counseling, and comprehensive reimbursement support for every patient who needs it,' said Kristin Williams, president of Amber Specialty Pharmacy. Amber Specialty Pharmacy streamlines the treatment process for both patients and referring providers by offering the following support services: Nationwide dispensing through its URAC and ACHC-accredited network 24/7 clinical support and adherence counseling from specialty-licensed pharmacists End-to-end benefits investigation, prior authorization and financial assistance coordination Healthcare providers can initiate BRINSUPRI referrals by calling (888) 370-1724 or visiting to download electronic referral forms. About Amber Specialty Pharmacy Amber Specialty Pharmacy is a pioneer in the specialty pharmacy industry, with more than 25 years of experience in providing specialized care for patients with chronic and complex medical conditions. With a focus on personalized support and quality clinical care, Amber Specialty Pharmacy serves patients across the United States. The pharmacy is accredited by both the Utilization Review Accreditation Commission (URAC) and the Accreditation Commission for Health Care (ACHC). Amber Specialty Pharmacy is headquartered in Omaha, Nebraska. To learn more, visit
Yahoo
8 hours ago
- Yahoo
Target-owned brand of frosted sugar cookies recalled due to possible contamination with wood pieces
So far, no illnesses have been reported. Frosted sugar cookies sold at Target stores across the United States have been recalled because they may contain pieces of wood. The U.S. Food and Drug Administration issued a recall for 803 cases of Favorite Day Bakery frosted sugar cookies sold at Target stores in 20 states and Washington, D.C. Favorite Day is a private label brand sold at Target. The voluntary recall was initiated on July 22, 2025, by Give and Go Prepared Foods Corp in Etobicoke, Canada, which prepared the affected bakery items. As of Aug. 13, Target does not have the recall listed on its website. How can I identify which specific cookies are recalled? The affected Favorite Day Bakery frosted sugar cookies are the 10-count packages (Net wt. 13.5 oz.) with lot number 25195 and UPC code 85239-41250 3. 'Best By Date can vary as they are applied by retailer when removed from freezer,' the FDA indicates in the recall. Has anyone gotten sick from the cookies? No illnesses have been reported yet. However, the FDA classified the recall as Class II, which means eating the contaminated cookies 'may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.' Where are the Target stores that sold the affected cookies? The FDA says the affected cookies were distributed to Target stores in the following states and D.C.: Connecticut Delaware Illinois Indiana Kentucky Maine Maryland Massachusetts Michigan Missouri New Hampshire New Jersey New York North Carolina Ohio Pennsylvania Rhode Island Tennessee Vermont Virginia Washington, D.C. I bought the cookies that were recalled. What should I do? Customers who purchased the affected frosted sugar cookies can get a full refund by bringing them to their nearest Target store or by calling Target guest relations at 1-800-440-0680. Solve the daily Crossword